Completed NA INTERVENTIONAL 1-arm NCT02634216

Effects of Capros in Patients With Type-1 Diabetes (CarposT1D)

Effects of Capros Supplementation on Hyperglycemia in Patients With Type-1 Diabetes

Sponsor: Natreon, Inc.

Interventions Capros

Updated 8 times since 2017 Last updated: Nov 18, 2019 Started: Jan 31, 2015 Primary completion: May 25, 2016 Completion: May 25, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type I Diabetes and is currently completed. Natreon, Inc. leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2018 — Dec 2019 [monthly]

Active Not Recruiting NA

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting NA
Feb 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Natreon, Inc.
Ohio State University

Data source: Ohio State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States